Why Kardigan, Inc.’s (KARD) Stock Is Up 7.92%
As of Friday, September 25, Kardigan, Inc.’s KARD share price has surged by 7.92%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The company incorporates Prolaio’s cardiovascular data collection and analytics platform, which includes FDA-cleared algorithms and high-density patient data, to support drug development and clinical intelligence. The company engages in strategic in-licensing and acquisitions to expand its pipeline of targeted treatments. Kardigan serves biopharmaceutical companies, cardiovascular researchers, and healthcare providers in the cardiology sector. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey.
Commentary & Analysis
Why Kardigan, Inc.’s (KARD) Stock Is Down 7.24%
As of Wednesday, September 23, Kardigan, Inc.’s KARD share price has dipped by 7.24%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Kardigan, Inc.’s (KARD) Stock Is Down 10.07%
As of Wednesday, September 23, Kardigan, Inc.’s KARD share price has dipped by 10.07%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Kardigan, Inc.’s (KARD) Stock Is Up 5.68%
As of Monday, September 21, Kardigan, Inc.’s KARD share price has surged by 5.68%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Kardigan, Inc.’s (KARD) Stock Is Up 5.16%
As of Friday, September 11, Kardigan, Inc.’s KARD share price has surged by 5.16%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | KARD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,345.5 | $559.4 | 49% |
|
| Shares Out (Mil) | 25.2 | 42.7 | 34% |
|
| Institutional Ownership | 73.1% | 84.1% | 44% |
|
| Float (Mil) | 51.8 | 45.1 | 48% |
|
| Beta | na | 0.72 | na |
|
| Avg Daily Volume (000s) | 1,267 | 431 | 72% |
|
| Price Change (52-week) |
na | 62.3% | na |
|
| Growth | KARD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.4% | na |
|
| Net Income (5yr) | na | (1.4%) | na |
|
| EPS (5yr) | na | 15.1% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.0%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.766) | ($4.544) | ($3.199) | |
| Month Ago EPS | ($0.735) | ($3.892) | ($3.132) | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (83.4%) | (69.4%) | (76.2%) | |
| Financials | KARD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $317 | na |
|
| Net Income (TTM) (Mil) | ($289) | ($11) | 5% |
|
| EPS (TTM) | ($17.125) | ($0.600) | 3% |
|
| Operating Cash Flow (TTM) (Mil) | ($206) | ($6) | 4% |
|
| Net Cash Flow (TTM) (Mil) | $316 | $5 | 87% |
|
| Long-Term Debt (Q1) (Mil) | $10 | $6 | 28% |
|
| Enterprise Value (Q1) (Mil) | $1,474 | $493 | 45% |
|
| Valuation | KARD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.18 | 2.42 | 55% |
|
| P/E | na | 16.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | KARD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.4% | na |
|
| Net Margin | na | 2.5% | na |
|
| ROA | (80.0%) | (22.0%) | 7% |
|
| ROE | (93.8%) | (21.8%) | 10% |
|
| Liabilities to Assets | 14.7% | 32.6% | 9% |
|
| F-Score | 1 | 3 | na |
|
Kardigan, Inc. did not pass any screens on 9/24/2026.
